Vimarsana
Biggest News Aggregation in the World

Page 2 - Dtx Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dtx Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dtx Pharma Today - Breaking & Trending Today

Strategic Collaborations and Innovation Drive Next Generation Drug Conjugates Market: North America Takes the Lead in This Rapidly Growing Sector - Vimarsana News

Strategic Collaborations and Innovation Drive Next Generation Drug Conjugates Market: North America Takes the Lead in This Rapidly Growing Sector

/PRNewswire/ -- The "Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of...

Advancing Beyond Antibody Drug Conjugates: Next Generation - Vimarsana News

Advancing Beyond Antibody Drug Conjugates: Next Generation

Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The

AbbVie acquires Parkinson's drug in latest biotech buyout - Vimarsana News

AbbVie acquires Parkinson's drug in latest biotech buyout

BioPharma

The Conjugation and Labeling Services Market is projected to grow at a CAGR of 10%, till 2035, according to a new market research report by Roots Analysis - Vimarsana News

The Conjugation and Labeling Services Market is projected to grow at a CAGR of 10%, till 2035, according to a new market research report by Roots Analysis

/PRNewswire/ -- Roots Analysis has announced the addition of "Conjugation and Labeling Services Market, 2023-2035" report to its list of offerings. A number of...

Impilo Therapeutics Launches to Enable Nucleic Acid-Based Medicines to Effectively Treat Solid Tumor Cancers - Vimarsana News

Impilo Therapeutics Launches to Enable Nucleic Acid-Based Medicines to Effectively Treat Solid Tumor Cancers

SAN DIEGO, Aug. 15, 2023 /PRNewswire/ -- Impilo Therapeutics, Inc. , a privately held drug discovery and development company, today announced that it has launched with the mission to enable nucleic... -Today at 08:31 am- MarketScreener